ACPU
Arrowgrass Capital Partners (US)’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $5.56M | Buy |
141,992
+6,238
| +5% | +$244K | 1.46% | 3 |
|
2019
Q3 | $4.88M | Buy |
135,754
+92,945
| +217% | +$3.34M | 0.36% | 28 |
|
2019
Q2 | $1.85M | Sell |
42,809
-8,894
| -17% | -$385K | 0.04% | 169 |
|
2019
Q1 | $2.2M | Buy |
51,703
+47,620
| +1,166% | +$2.02M | 0.06% | 139 |
|
2018
Q4 | $178K | Buy |
+4,083
| New | +$178K | 0.01% | 165 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 185 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 174 |
|
2018
Q1 | – | Sell |
-187,384
| Closed | -$6.79M | – | 239 |
|
2017
Q4 | $6.79M | Buy |
187,384
+119,233
| +175% | +$4.32M | 0.07% | 104 |
|
2017
Q3 | $2.43M | Sell |
68,151
-269,605
| -80% | -$9.62M | 0.02% | 199 |
|
2017
Q2 | $11.3M | Buy |
337,756
+333,189
| +7,296% | +$11.2M | 0.09% | 128 |
|
2017
Q1 | $156K | Sell |
4,567
-78,501
| -95% | -$2.68M | ﹤0.01% | 270 |
|
2016
Q4 | $2.7M | Buy |
83,068
+38,642
| +87% | +$1.26M | 0.03% | 131 |
|
2016
Q3 | $1.51M | Sell |
44,426
-107,612
| -71% | -$3.65M | 0.02% | 153 |
|
2016
Q2 | $5.35M | Buy |
152,038
+34,367
| +29% | +$1.21M | 0.06% | 84 |
|
2016
Q1 | $3.49M | Sell |
117,671
-1,151,014
| -91% | -$34.1M | 0.04% | 118 |
|
2015
Q4 | $41M | Buy |
1,268,685
+1,061,720
| +513% | +$34.3M | 0.5% | 21 |
|
2015
Q3 | $6.5M | Sell |
206,965
-88,904
| -30% | -$2.79M | 0.12% | 70 |
|
2015
Q2 | $9.92M | Buy |
+295,869
| New | +$9.92M | 0.15% | 75 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 292 |
|
2014
Q3 | – | Sell |
-730,780
| Closed | -$21.7M | – | 232 |
|
2014
Q2 | $21.7M | Buy |
+730,780
| New | +$21.7M | 0.64% | 32 |
|